tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CRVS Stock Latest News

Corvus Pharmaceuticals’ Earnings Call: Progress Amid Challenges
Company AnnouncementsCorvus Pharmaceuticals’ Earnings Call: Progress Amid Challenges
6d ago
CRVS
Corvus Pharmaceuticals price target raised to $15 from $14 at Oppenheimer
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $15 from $14 at Oppenheimer
7d ago
CRVS
Corvus Pharmaceuticals Reports 2024 Financial Results and Clinical Progress
PremiumCompany Announcements
Corvus Pharmaceuticals Reports 2024 Financial Results and Clinical Progress
7d ago
CRVS
Corvus Pharmaceuticals reports Q4 EPS (18c), consensus (12c)
PremiumThe Fly
Corvus Pharmaceuticals reports Q4 EPS (18c), consensus (12c)
7d ago
CRVS
Options Volatility and Implied Earnings Moves Today, March 25, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 25, 2025
8d ago
GME
MKC
Corvus announces presentation of data from Phase 1/1b trial of soquelitinib
PremiumThe FlyCorvus announces presentation of data from Phase 1/1b trial of soquelitinib
13d ago
CRVS
Corvus Pharmaceuticals announces initiation of Phase 2 trial of soquelitinib
Premium
The Fly
Corvus Pharmaceuticals announces initiation of Phase 2 trial of soquelitinib
21d ago
CRVS
CRVS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CRVS Upcoming Earnings Report: What to Expect?
29d ago
CRVS
Corvus Pharmaceuticals Reports Promising Interim Data on Soquelitinib
PremiumCompany Announcements
Corvus Pharmaceuticals Reports Promising Interim Data on Soquelitinib
3M ago
8K
CRVS
Corvus announces data from cohort 2 of Phase 1 trial of Soquelitinib
PremiumThe Fly
Corvus announces data from cohort 2 of Phase 1 trial of Soquelitinib
3M ago
CRVS
Alphabet, Uber downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alphabet, Uber downgraded: Wall Street’s top analyst calls
3M ago
AYI
LHX
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
3M ago
CRVS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
AVXL
CRVS
Corvus selloff on atopic dermatitis data ‘way overdone,’ says Mizuho
Premium
The Fly
Corvus selloff on atopic dermatitis data ‘way overdone,’ says Mizuho
3M ago
CRVS
Corvus Pharmaceuticals Reports Promising Phase 1 Data and Financial Boost
Premium
Company Announcements
Corvus Pharmaceuticals Reports Promising Phase 1 Data and Financial Boost
3M ago
8K
CRVS
Corvus Pharmaceuticals announce interim data from Phase 1 trial of soquelitinib
PremiumThe Fly
Corvus Pharmaceuticals announce interim data from Phase 1 trial of soquelitinib
3M ago
CRVS
Closing Bell Movers: Heico slips 7% after Q4 results
PremiumThe Fly
Closing Bell Movers: Heico slips 7% after Q4 results
4M ago
LW
ENS
Corvus publishes data on potential of soquelitinib to modulate tumor activity
PremiumThe Fly
Corvus publishes data on potential of soquelitinib to modulate tumor activity
4M ago
CRVS
Corvus Pharmaceuticals announces preclinical dataon soquelitinib
PremiumThe Fly
Corvus Pharmaceuticals announces preclinical dataon soquelitinib
5M ago
CRVS
Corvus Pharmaceuticals price target raised to $13 from $8 at Jefferies
PremiumThe FlyCorvus Pharmaceuticals price target raised to $13 from $8 at Jefferies
5M ago
CRVS
Corvus Pharmaceuticals price target raised to $24 from $21 at Ladenburg
Premium
The Fly
Corvus Pharmaceuticals price target raised to $24 from $21 at Ladenburg
5M ago
CRVS
Corvus Pharmaceuticals price target raised to $14 from $8 at Oppenheimer
Premium
The Fly
Corvus Pharmaceuticals price target raised to $14 from $8 at Oppenheimer
5M ago
CRVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >